Member Info for chester18

Ruck,

I read inans post and knew exactly what he meant. Your just twisting words to cause some kind of debate.

In trying to pick at a thread you are coming across as non to bright.

I suggest you think before you post.

Chester.

Yes, they need to eliminate Coronavirus so cancer trials can get underway in a safer world.
Also they can build a time machine and go back 3 years to convince the FDA not to be so picky on the Ichor device.
Or even further back and stop all the wasted cancer vaccine failures that meant SCIB1 became unattractive.

Hindsight is not what is needed here, what we need is this pandemic to be defeated so Scancell can be allowed to proceed.

Chester.

Hi PC01

The transaction relating to todays RNS was over a year ago. So what ever he was doing then is now irrelevant.

What is more relevant is why it has come to light and why it is now so important to correct. It may be nothing but there are a few things at the moment that could all be tied together. I am intrigued.

Chester.

Also just had this thought.......

Is there some reason that RENE need to tidy up the legals.......??????

Interesting ...... or maybe not...

Chester.

He is a large private investor. He has just taken a significant position in one of my other holdings (TRX). Also this transaction is backdated to 5th March 2019 so more to do with tidying up the paperwork than anything to concern us private investors.

Chester.

An engineer friend of mine when asked about the delivery date of a particularly difficult job, said :

"Foam wasn't spilt in a Tray" .......

Which I think was very succinct ...

Chester.

Thank you Paddy, lets hope that those holes do get a mention as to why they are there...

Greedo76, I totally accept your point that we can't keep on expecting outstanding results, but that could have been true 3 reports back.

The thing that goes against your proposition is that there seems to be no let up in the pace of the drilling.
Plus they have already stated that they aim to drill a further 80,000 mtrs...... so maybe Melbourne is on the map..... : )

Chester.

Excellent post MRK2020

With all the information we have on the current running costs as gleaned from their gross turnover against their losses for the last 4 years, it is my guess that they could currently operate at break-even between £20m and £24m turnover.

I know they stated that the deal with the top ten global healthcare provider when in full swing will add many millions to their sales, it will probably be at quite a low margin but also a massive contributor to the overall running costs.

So adding up your post plus the current possible 2020 turnover of approx £16.5m it would not be incomprehensible to see the year end figure for 2022 to be heading towards £60m. That would be very impressive and also mean they would be generating a very healthy annual profit anywhere between £ 15m and £20m. That equates to between 2.2p to 2.85p profit per share and you can buy today at 0.34p.

No wonder that Lombard Odier Asset Management are loading up, if that all comes to pass.......

Chester.

Hi Paddy

The new image shows that there are some big gaps in our knowledge and some will be filled next Wednesday.
Some others I take it we will need to wait until Octobers report.

I did ask if we are likely to be given reasons for the SW holes around the dunes but you intimated that you did not expect Newcrest to mention why they those holes have been drilled.

What is it that makes you think they will still want to keep them under wraps ?

Chester.

Morning Onceaday

As has been pointed out by GrizzlyB, Micheal Hunt is presenting next Tuesday night at 6.30pm (20 minute slot) at the Share Investors Evening.

Fingers crossed that some news is brewing that is holding up the notification. As GB said it could be nothing and we're just adding 2 & 2 and getting 5, but who cares it's fun to dream of the chances it's a mega deal, done...... : )

Chester.

Hi Sam 747

Some have posted that they had the sign a form and return it to their broker. As Jadedoctor advises you should contact your broker and check your account with Primary Bid.

Chester.

Its still very difficult to separate out all the buys from the sells.

Looking at yesterday the 0.33p x 2.5m trade, that is a definite sell but where can we draw the line as there is another 2.5m trade at 0.3352 and later another 'red' sell at .33651.

So if we say that yesterday from early morning that 0.3371 is the sell line, all the trades in 'blue' below that price are sells and everything above are buys.

With the spread being so thin the MM's are disguising the trading direction and all the time Lombard Odier Asset Management are increasing their position, don't be surprised if we receive another Holdings RNS by tomorrow.

It would be very nice to have some news from the company by the end of this month but I'm not holding my breath.

As I heard a chap say as he stood in queuing outside a lockdown pub 'Patience will be rewarded' ..........

Chester.

No Responses to my post .....

So what are we looking forward to in next Wednesdays Quarterly Report......?

Chester.

Next weeks quarterly report could be the best so far.......

From the satellite images we know there are some big holes in our knowledge of exactly what Newcrest has found.

The info around the SW beyond the Dunes and the large step outs could make a huge difference to what we think is the minimum resource.

We don't need the frenzy before the report because this time it might just happen, after the report.

Chester.

RENE have stated that the year end report will be released sometime in July.

So on the basis that Monday is virtually half way through the month I'm going to stick my neck out and say that we should be told 'the actual date' at some point this week.

I'm still very hopeful that the report will also include news on the first Exosomes collaboration.

Chester.

Hi Bunsie

Comparing SCLP to an Oilie was just a way of explaining the market reaction the day an RNS was released saying that the SCIB1 plus Keytruda had eradicated 55% ++ of the target cancers. The SP would jump upwards on the pandemonium.

The point being that this share will not progress sedately in well defined increases with the BOD driving the company ever forward. It will bounce around and then a positive RNS it will double or treble or more.

"Sentiment is All' .........
the slogan from a tv series called 'The Last Scancell'............. : )

Chester.

Where's that Nomlungu.....

I told him there could be another Holding RNS in the pipeline ......lol

Great to see a large investor grabbing as much as they can. Some of the large trades that look like sells are obviously buys. The MM's are doing a good job of confusing us private investors. They just want your shares to fill forward orders.

Hold on tight because this will turn round when the company begin to RNS updates and news on deals.

Chester.

I have never heard such a load of nonsense.

Our individual investments in Scancell could turn out to be Charlie Wonka's Golden Tickets the day positive data is announced on either SCIB1 or MODI1.

The price would go from whatever it is that day , let's say 15p to £'s? and if a large Pharma company decided they wanted the whole IP it could be 10's of £'s per share.

Scancell can be likened to an oil discovery, the day the oil starts to flow the value becomes many times the SP.

And, it is just a Matter of Time, anyone who appreciates the time journey from discovery to licensed drug will tell you that 15 to 20 years is not unusual.

Some on hear think it should all be hurried up to suit their wishes or circumstances.

Clap trap of the highest order .

Chester.

Hi Stakis

Due to the FDA holding up the SCIB1 / Combi trial for 2.1/2 years plus CV-19 stopping most if not all cancer trials in their tracks, we will probably need to raise more capital. If that happens I hope it's an Open Offer so private investors can take part as I will definitely take part.

My point earlier was that if you believe that when Scancells cancer platforms are actually put into clinical trials that they will work, in humans as they did in mouse models, then it's just a matter of time. The SCIB 1 trials in Melanoma have already proved that the modality, as designed by Scancell does work.

If you put money in a five year bond what would be the possible return, set that against the possibility of a successful Scancell in 5 years. The only hurdle is our perception of the risk that Scancell amounts to nothing but that's the reason we do research. If during your research into Scancell you become unsure of their potential to succeed, then don't invest. Find an investment that you are confident of becoming successful.

With Scancell I fall into the camp of 'glass half full'. Given the resources I will continue to buy especially at the current price.

Also we must consider C7's point that in early September the first AvidiMab collaboration/ agreement reaches 12 months, so there has to be a decision at that point. It could well be the first deal with two others in the pipeline.

That incoming money may well see us through to first glimpses of data from the SCIB1 trial.

I know it's hard but patience is the name of the game. The science, the IP, the Patents and the Trial Approvals are there in place it's just a matter of time.

Chester.

The current MCap is now £25m given that we reach 'the day' when both Scib1 + Keytruda and Modi1 have proved themselves with successful Data, what will the IP and all the Patent Protection be worth ?? How many 100's of millions ?

5.45p is a price based on the current demand for the share in the wider market. If a fully researched investor in Scancell truly believes that that day will arrive, they will see 5.45p as an opportunity to acquire more shares.

I don't welcome the delays that have been visited upon Scancell but I do appreciate the fact that I have been able to build a shareholding I could have only fantasised about when the SP was at 15p.

So we are the market, why would we not help ourselves to these ridiculously cheap shares.

Chester.